Reporting Diseases and Conditions

New York City's Health Code Article 11 requires that certain diseases and conditions be reported to DOHMH immediately and others within 24 hours. Please see below for more information.

Download How to Report Diseases, Events, and Conditions to the New York City Health Department (PDF).

Directions for Provider Reporting

Group A cases should be reported immediately upon suspicion (without waiting for laboratory confirmation) by calling the Provider Access Line (PAL) at (866) 692-3641. The following public health threats should also be reported immediately:

  • Suspected outbreaks (three or more cases) of any disease
  • Any unusual manifestation of a disease or condition of public health interest
  • A newly apparent or emerging disease or syndrome that could be communicable

Group B cases should also be reported immediately to the PAL at (866) 692-3641 if the case meets any of this risk group criteria:

  • Food handler in a commercial establishment
  • Staff member or child (aged <6) in a school, daycare facility, camp or other congregate setting
  • Resident or staff member in a correctional facility, homeless facility, or other congregate residence
  • Healthcare practitioner in a medical facility that provides oral care

Group C cases should be reported within 24 hours using online via NYCMED. If necessary, most can also be reported by mailing or faxing the Universal Reporting Form.

Reportable Diseases and Conditions

  • Amebiasis
  • Anaplasmosis (human granulocytic)
  • Animal bite (also see rabies) (a)
  • Anthrax
  • Arboviral infections, acute (b)
  • Babesiosis
  • Botulism (including infant, foodborne, and wound) (c)
  • Brucellosis
  • Campylobacteriosis
  • Carbon Monoxide poisoning (c)
  • Chancroid
  • Chikungunya
  • Chlamydia
  • Cholera
  • Creutzfeldt-Jakob disease
  • Cryptosporidiosis
  • Cyclosporiasis
  • Dengue
  • Diphtheria
  • Drowning (whether resulting in death or not)
  • Ehrlichiosis (human monocytic)
  • Encephalitis
  • Escherichia coli O157:H7 infection
  • Falls from windows (children aged ≤16) (d)
  • Food poisoning (in two or more individuals)
  • Giardiasis
  • Glanders
  • Gonorrhea
  • Granuloma inguinale (donovanosis)
  • Hantavirus
  • Hemolytic uremic syndrome
  • Haemophilus influenzae disease, invasive
  • Hepatitis A
  • Hepatitis B, acute
  • Hepatitis B in a pregnant woman or post-partum woman (e)
  • Hepatitis B - test result of an infant born to a positive mother
  • Hepatitis C, acute only
  • Herpes, neonatal (infants aged ≤ 60 days)
  • HIV/AIDS (f)
  • Influenza, novel strain with pandemic potential (e.g., avian h3N1, H7N9)
  • Influenza-related pediatric death (child aged ≤18)
  • Legionellosis
  • Leprosy (Hansen’s disease)
  • Leptospirosis
  • Listeriosis
  • Lyme disease
  • Lymphocytic choriomeningitis virus
  • Lymphogranuloma venereum
  • Malaria
  • Measles (rubeola)
  • Melioidosis
  • Meningitis, bacterial causes
  • Meningococcal disease, invasive (including meningitis)
  • Monkeypox
  • Mumps
  • Paratyphoid fever
  • Pertussis (whooping cough)
  • Plague
  • Poisoning by drugs or other toxic agents (c)
  • Poliomyelitis
  • Psittacosis
  • Psychosis, first episode (patients aged 18-30) (g)
  • Q fever
  • Rabies and exposure to rabies (e.g. animal bite) (a)
  • Ricin poisoning (c)
  • Rickettsialpox
  • Rocky Mountain spotted fever
  • Rubella (German measles)
  • Rubella syndrome, congenital
  • Salmonellosis
  • Severe or novel coronavirus (e.g., SARS, MERS-CoV)
  • Shiga toxin-producing Escherichia coli (STEC) infection
  • Shigellosis
  • Smallpox (variola)
  • Staphylococcal enterotoxin B poisoning
  • Staphylococcus aureus, vancomycin intermediate (VISA) and resistant (VRSA)
  • Streptococcus (Group A), invasive
  • Streptococcus (Group B), invasive
  • Syphilis, all stages, including congenital
  • Tetanus
  • Toxic shock syndrome
  • Trachoma
  • Transmissible spongiform encephalopathies (including Creutzfeldt-Jakob disease)
  • Trichinosis
  • Tuberculosis (h)
  • Tularemia
  • Typhoid fever
  • Vaccinia disease (adverse events associated with smallpox vaccination)
  • Vibrio species, non-cholera
  • Viral hemorrhagic fever (e.g. Ebola)
  • West Nile viral neuroinvasive disease (e.g., meningitis, encephalitis)
  • West Nile fever
  • Yellow fever
  • Yersiniosis, non-plague
  • Zika


  1. Immediately report an animal bite from vector species at higher risk for rabies (including raccoons, skunks, foxes and bats) or any mammal with illness suggestive of rabies. You can report a bite by calling (646) 364-1799 or online.
  2. For example, Japanese encephalitis virus, and Rift Valley fever virus, among others. If Chikungunya, Dengue, West Nile virus, or yellow fever, report as such.
  3. Call the Poison Control Center at (212) 764-7667 (212-POISONS) for confidential treatment advice or to report poisonings, including: carbon monoxide and/or a carboxyhemoglobin level above 10% (report immediately), blood lead levels ≥ 10 µg/dL (within 24 hours) and < 10 µg/dL (within five days if using a point-of-care device), and pesticide, both suspected and confirmed cases (report within 24 hours).
  4. Report falls (children ages ≤16) from windows in buildings with three or more dwellings by calling (212) 764-7667.
  5. Report chronic and acute cases of hepatitis B in pregnant or post-partum patients using Reporting Central or the IMM-5 form. Call (347) 396-2403 for more information. Other chronic cases of hepatitis B and hepatitis C are no longer reportable by providers.
  6. Report all diagnoses of HIV infection, HIV-related illness, and AIDS within 14 days using the New York State Provider Report Form (PRF). Call (518) 474-4284 for forms, or (212) 442-3388 for more information.
  7. Report first hospital admission of persons (aged 18-30) with any of the following diagnoses: Schizophrenia (any type), Psychosis NOS (not otherwise specified), Schizophreniform Disorder, Delusional Disorder, Shizoaffective Disorder, Brief Psychotic Disorder, Shared Pyschotic Disorder, Other Schizophrenia Spectrum and Other Psychotic Disorder.
  8. Report any suspected or confirmed tuberculosis cases, including: positive AFB smears, positive nucleic acid amplification tests, positive M. TB cultures, pathology findings consistent with TB, start of TB treatment with 2 or more anti-TB drugs, and, in children aged ≤ 5, positive tests for TB infection (Mantoux test or FDA-approved blood test), and clinical suspicion for TB even without positive TB test.